
About NII
NII is a company based in Delhi (India) founded in 1981. Advanced immunological research and vaccine development are conducted. Its website nii.res.in draws about 31 thousand monthly visits. NII offers products and services including Immunology Research Services and Academic and Training Services. Its legal entity is National Institute of Immunology.
Company details
Provider of advanced immunological research and development. This entity conducts cutting-edge research in immunology and related sciences, focusing on the development of improved diagnostics, treatments, and vaccines. It brings together interdisciplinary research teams to enhance understanding of the immune system and its applications in human health. The organization offers doctoral and postdoctoral programs, fostering the training of future immunologists. Furthermore, it engages in technology transfer and collaborates with academic institutions and industry partners to translate research findings into practical applications.
- Headquarters Delhi, India
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website nii.res.in
- Social LinkedIn X Facebook YouTube
- Legal Name National Institute Of Immunology
- InvestorsHHS
& 1 more
Products & Services of NII
NII offers a comprehensive portfolio of products and services, including Immunology Research Services and Academic and Training Services.
Research is carried out on immune system mechanisms for disease protection and variants like COVID-19.
Programs are delivered for doctoral, post-doctoral, and short-term training in biotechnology fields.
Apps and channels of NII
its YouTube channel National Institute of Immunology, New Delhi has 1.29K subscribers and 29 videos.
Videos from NII
The most watched videos on NII's YouTube channel, National Institute of Immunology, New Delhi (1.29K subscribers). Click a video to play it here.
Funding Insights of NII
- Total Rounds 5
- First Round $222,133
(Dec 2007)
- Investors Count 2
All 5 funding rounds of NII with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | Grant | β | β | ||
| May 2011 | $222,133 | Grant | β | β | |
| May 2010 | $150,534 | Grant | β | β | |
| Apr 2008 | $150,534 | Grant | β | β | |
| Dec 2007 | $222,133 | Grant | β | β |
2 investors in total: 2 institutional.
Investors in NII
NII has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for NII
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NII
3 dated milestones of NII across 39 years, from founding to its latest funding, stage changes and deals.
- Founded NII is founded.
- Funding First funding round of $222K.
- Funding Latest funding round, Grant,.
Web traffic of NII
The website of NII (nii.res.in) receives about 30.7K visits a month.
- Monthly visits30.7K
▼ 13.4% vs previous month
Websites whose visitors overlap most with NII. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| icmr.nic.in | 100% | #2,169,284 | View details | ||
icmr.gov.in | icmr.gov.in | 90% | #141,466 | β | |
| nib.gov.in | 90% | 12.3K | #1,943,561 | View details | |
| venueyeinstitute.org | 86% | 1.3K | #10,279,063 | View details | |
bloodindex.net | bloodindex.net | 86% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 31 similar websites and full traffic analytics for NII
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 31 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NII
NII was founded in 1981 and raised its 1st funding round 26 years after it was founded.
NII is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Provider of advanced immunological research and development. This entity conducts cutting-edge research in immunology and related sciences, focusing on the development of improved diagnostics, treatments, and vaccines. It brings together interdisciplinary research teams to enhance understanding of the immune system and its applications in human health. The organization offers doctoral and postdoctoral programs, fostering the training of future immunologists. Furthermore, it engages in technology transfer and collaborates with academic institutions and industry partners to translate research findings into practical applications.
NII offers Immunology Research Services and Academic and Training Services.
NII has 2 investors. Key investors include HHS, and European Union.
NII operates through National Institute Of Immunology.